Removing 10% of a patient's blood before major liver surgery and giving it back afterwards reduced transfusions by half, according to a large clinical trial published in The Lancet Gastroenterology & ...
Molecular subtypes and outcomes in regorafenib-treated patients with metastatic colorectal cancer (mCRC) enrolled in the CORRECT trial. Effects of regorafenib (REG) therapy on health-related quality ...
Removing 10% of a patient's blood before major liver surgery and giving it back afterwards reduced transfusions by half, according to a large clinical trial published in The Lancet Gastroenterology & ...
Toxicity Index, Patient-Reported Outcomes, and Early Discontinuation of Endocrine Therapy for Breast Cancer Risk Reduction in NRG Oncology/NSABP B-35 Between March 2007 and January 2019, 300 patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results